Treatment of liver. NASH new information.

                                     FDA approved .... 

                                A new development for 

                              Treatment of liver.

• The Food and Drug Administration approved Rezdiffra as the first-ever treatment for a common and potentially deadly liver disease nonalcoholic steatohepatitis, or NASH that affects millions worldwide.
• The FDA’s decision means Madrigal Pharmaceuticals has succeeded in a disease area that several larger companies have failed — or are still trying to break into.
• Novo Nordisk and Eli Lilly are testing their respective blockbuster weight loss injections as treatments for the same kind of liver disease, called nonalcoholic steatohepatitis, or NASH.
• https://bioworldhealthcare.blogspot.com/
• email : bioworldhc@gmail.com
•